Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 2
1979 1
1980 1
1981 3
1983 1
1984 1
1985 5
1986 2
1987 2
1988 5
1989 4
1990 3
1991 10
1992 7
1993 7
1994 10
1995 5
1996 6
1997 21
1998 8
1999 13
2000 12
2001 20
2002 18
2003 26
2004 16
2005 8
2006 15
2007 20
2008 20
2009 15
2010 18
2011 20
2012 7
2013 9
2014 9
2015 5
2016 9
2017 7
2018 4
2019 2
2020 4
2021 3
2022 5
2023 3

Text availability

Article attribute

Article type

Publication date

Search Results

367 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.
Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, Cottin V, Flaherty KR, Hansell DM, Inoue Y, Kim DS, Kolb M, Nicholson AG, Noble PW, Selman M, Taniguchi H, Brun M, Le Maulf F, Girard M, Stowasser S, Schlenker-Herceg R, Disse B, Collard HR; INPULSIS Trial Investigators. Richeldi L, et al. Among authors: du bois rm. N Engl J Med. 2014 May 29;370(22):2071-82. doi: 10.1056/NEJMoa1402584. Epub 2014 May 18. N Engl J Med. 2014. PMID: 24836310 Free article. Clinical Trial.
A simplified workflow for monoclonal antibody sequencing.
Meyer L, López T, Espinosa R, Arias CF, Vollmers C, DuBois RM. Meyer L, et al. PLoS One. 2019 Jun 24;14(6):e0218717. doi: 10.1371/journal.pone.0218717. eCollection 2019. PLoS One. 2019. PMID: 31233538 Free PMC article.
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials.
Noble PW, Albera C, Bradford WZ, Costabel U, Glassberg MK, Kardatzke D, King TE Jr, Lancaster L, Sahn SA, Szwarcberg J, Valeyre D, du Bois RM; CAPACITY Study Group. Noble PW, et al. Among authors: du bois rm. Lancet. 2011 May 21;377(9779):1760-9. doi: 10.1016/S0140-6736(11)60405-4. Epub 2011 May 13. Lancet. 2011. PMID: 21571362 Clinical Trial.
An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features.
Fischer A, Antoniou KM, Brown KK, Cadranel J, Corte TJ, du Bois RM, Lee JS, Leslie KO, Lynch DA, Matteson EL, Mosca M, Noth I, Richeldi L, Strek ME, Swigris JJ, Wells AU, West SG, Collard HR, Cottin V; “ERS/ATS Task Force on Undifferentiated Forms of CTD-ILD”. Fischer A, et al. Among authors: du bois rm. Eur Respir J. 2015 Oct;46(4):976-87. doi: 10.1183/13993003.00150-2015. Epub 2015 Jul 9. Eur Respir J. 2015. PMID: 26160873 Free article.
An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease.
Meyer KC, Raghu G, Baughman RP, Brown KK, Costabel U, du Bois RM, Drent M, Haslam PL, Kim DS, Nagai S, Rottoli P, Saltini C, Selman M, Strange C, Wood B; American Thoracic Society Committee on BAL in Interstitial Lung Disease. Meyer KC, et al. Among authors: du bois rm. Am J Respir Crit Care Med. 2012 May 1;185(9):1004-14. doi: 10.1164/rccm.201202-0320ST. Am J Respir Crit Care Med. 2012. PMID: 22550210
Sarcoidosis.
Baughman RP, Lower EE, du Bois RM. Baughman RP, et al. Among authors: du bois rm. Lancet. 2003 Mar 29;361(9363):1111-8. doi: 10.1016/S0140-6736(03)12888-7. Lancet. 2003. PMID: 12672326 Review.
Sarcoidosis.
Hart LA, Conron M, du Bois RM. Hart LA, et al. Among authors: du bois rm. Int J Tuberc Lung Dis. 2001 Sep;5(9):791-806. Int J Tuberc Lung Dis. 2001. PMID: 11573890 Review.
Cardiac sarcoidosis.
Mitchell DN, du Bois RM, Oldershaw PJ. Mitchell DN, et al. Among authors: du bois rm. BMJ. 1997 Feb 1;314(7077):320-1. doi: 10.1136/bmj.314.7077.320. BMJ. 1997. PMID: 9040314 Free PMC article. No abstract available.
Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis.
Richeldi L, Costabel U, Selman M, Kim DS, Hansell DM, Nicholson AG, Brown KK, Flaherty KR, Noble PW, Raghu G, Brun M, Gupta A, Juhel N, Klüglich M, du Bois RM. Richeldi L, et al. Among authors: du bois rm. N Engl J Med. 2011 Sep 22;365(12):1079-87. doi: 10.1056/NEJMoa1103690. N Engl J Med. 2011. PMID: 21992121 Free article. Clinical Trial.
Interstitial lung disease in systemic sclerosis: a simple staging system.
Goh NS, Desai SR, Veeraraghavan S, Hansell DM, Copley SJ, Maher TM, Corte TJ, Sander CR, Ratoff J, Devaraj A, Bozovic G, Denton CP, Black CM, du Bois RM, Wells AU. Goh NS, et al. Among authors: du bois rm. Am J Respir Crit Care Med. 2008 Jun 1;177(11):1248-54. doi: 10.1164/rccm.200706-877OC. Epub 2008 Mar 27. Am J Respir Crit Care Med. 2008. PMID: 18369202 Clinical Trial.
367 results